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Abstract  
Pulmonary toxoplasmosis is rare, particularly in the era of HAART. Here, we describe 
two severe cases in patients not known to be HIV-infected. In both, early diagnosis and 
therapy led to a favourable outcome. Pulmonary toxoplasmosis should be considered in 
the differential diagnosis in potentially HIV-infected patients with respiratory symptoms.  
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Introduction 
Highly active antiretroviral therapy (HAART) and antibiotic prophylaxis against 
opportunistic infections have resulted in a dramatic decrease of morbidity and mortality 
[1-3]. However, patients infected with HIV – also in developed countries - may still 
present with severe opportunistic infections. Most of these events are among those 
newly diagnosed with HIV at late stage of disease [4-6]. 
     Toxoplasmosis is the most common parasitic opportunistic infection of the central 
nervous system in AIDS patients, who are not on appropriate prophylaxis [7]. 
Extracerebral sites may be involved with or without toxoplasmic encephalitis [8-11]. HIV-
related pulmonary toxoplasmosis was first described in 1984. It was responsible for less 
than 1% of the pulmonary complications of HIV infection [12]. In a French national 
survey, the prevalence of extracerebral toxoplasmosis among HIV-infected patients in 
the pre-HAART era was 1.5-2 %. Of 199 patients with extracerebral toxoplasmosis, the 
lungs were involved in 26% and were the second most common extracerebral site after 
involvement of the eyes [9]. Here, we present two cases with pulmonary toxoplasmosis. 
 
Case 1 
A 26-year old Brazilian heterosexual patient presented to the emergency department 
because of a 3-day history of malaise, rapid progressive dyspnea, chest pain and fever, 
but no cough. In addition he complained about diarrhea and weight loss of 4kg  during 
the past 4 months. His medical history was unremarkable. He was not known to be HIV 
positive. On examination the patient was alert and oriented but in respiratory distress. 
His temperature was 37.8°C, blood pressure 110/45 mmHg, puls 127/min; the 
respirations were 50-60 breaths per minute, with an oxygen saturation of 50% without 
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supplemental oxygen. Chest examination did not reveal rhonchi or crackles. The axillar 
and inguinal lymph nodes were enlarged; the remainder of the examination normal. A 
chest radiograph showed extensive diffuse bilateral alveolar infiltrates (Figure 1A). An 
electrocardiogram was unremarkable. Laboratory test results included a mild normocytic 
anemia with a haemoglobin level of 11.1 g/dl, a lymphcytopenia with 410 cells/µl, C-
reactive protein (CRP) of 175 mg/l (<5), an elevated lactate dehydrogenase (LDH) of 
2640 U/L (240-420) and an aspartate aminotransferase (AST) of 130 U/L (10-50). A 
blood gas analysis with room air revealed a partial pressure of O2 (pO2) of 5.1 kPa, a 
partial pressure of CO2 (pCO2) of 3.5 kPa and a pH of 7.47. An HIV test turned out 
positive. The patient was transferred to the intensive care unit. Besides ceftriaxone and 
clarithromycine, high-dose trimethoprim-sulfamethoxazole and prednisone were started. 
During the next day his condition worsened, with increasing dyspnea and respiratory 
exhaustion and mechanical ventilation was required. CD4 cell count was 21 cells/µl and 
an HIV-1 viral load was 348’000 copies/ml. A bronchoalveolar lavage (BAL) was 
performed. In Giemsa and indirect immunofluorescence stains toxoplasma tachyzoites 
were identified (Figure 1B and 1C). There was no evidence of Pneumocystis  jirovecii 
and acid-fast bacilli. Toxoplasma serology turned out highly positive with IgG >549 IU/L 
and negative IgM antibodies. Pulmonary toxoplasmosis with acute respiratory distress 
syndrome (ARDS) in a patient with advanced HIV-infection was diagnosed. Therapy was 
changed to sulfadiazine and pyrimethamine plus folinic acid. After 3 days the patient 
was extubated and subsequently recovered rapidly. He was discharged from the 
hospital 4 days later.  
 
Case 2 
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A 38-year old immigrant from Nigeria was admitted with low grade temperature, 
productive cough lasting for 14 days, progressive headache for a few days and 
aggressive behaviour on admission day. His medical history was unremarkable.  
On admission his body temperature was 36.7° C, blood pressure 110/77 mmHg, heart 
rate 60/min, frequency of respiration 14/min and pulmonary examination revealed 
generalized wheezing. The patient was confused and somnolent with a fluctuating 
Glasgow coma scale between 5-13. He had ataxia and dysarthry but no meningeal 
symptoms. Significant laboratory values were as follows: microcytic anemia with a 
haemoglobin level of 10.3 g/dl, lymphopenia with 440 cells/µl, CRP 15mg/l (<5) , LDH 
636 U/l (150-420), AST 85 U/L (<50) and ALT 80 U/L (<50). HIV serology turned out to 
be positive. The CD4 cell count was 5 cells/µl and HIV1-RNA 1’620’000 copies/ml.  
Assays for toxoplasma antibodies were positive for IgG (not quantified) and negative for 
IgM. An electrocardiogram was normal. Chest x-ray revealed bilateral, diffuse patchy 
infiltrates and increased interstitial striation. Chest computed tomography (CT) scan 
showed also bilateral, patchy infiltrates (Figure 1D) and in a cranial CT scan edema and 
midline shift was found. One day later, cranial magnetic resonance imaging (MRI) 
revealed multiple abscesses. CNS lymphoma was ruled out by positron emission 
tomography (PET) scan. A BAL was performed: Giemsa stained specimen revealed 
tachyzoites of Toxoplasma gondii together with cysts of P. jirovecii (Figure 1E) that were 
confirmed by toluidine blue O staining (Figure 1F) and immunofluorescence staining (not 
shown). Pulmonary and cerebral toxoplasmosis with contemporaneous pulmonary 
pneumocystis infection was diagnosed. Treatment with sulfadiazine, pyrimethamine, 
folinic acid and atovaquone was started. The former drug was prescribed instead of 
trimethoprim-sulfamethoxazole to minimize sulphonamide toxicity. In the following days 
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the patient’s condition progressively improved. After 17 days he was discharged from 
the hospital.  
 
Discussion 
Here we present two cases of pulmonary toxoplasmosis. This is a very rare 
manifestation of a common opportunistic infection in AIDS patients. Strikingly in both 
patients the HIV status was unknown when they presented in the emergency room.  
The first case illustrates that pulmonary toxoplasmosis can rapidly progress to a life 
threatening state. Toxoplasma pneumonitis is also known to cause severe systemic 
infections with ARDS [13]. 
     The second patient presented with toxoplasmosis manifesting in two locations and in 
addition contemporaneously suffered from a second opportunistic infection: a P. jirovecii 
pneumonia. Toxoplasmosis involving several locations have been described [8, 10, 11]. 
In a French case series 11 of 64 patients (17%) presented with toxoplasmosis including 
lungs and the brain [14]. In addition there are rare published reports of patients with 
concurrent pulmonary toxoplasmosis and pneumocystis infection [8, 14]. However, these 
reports originated from the pre-HAART era, when in general the incidence of 
opportunistic infections was higher by magnitudes in developed countries when 
compared to today [15]. 
     Usually Toxoplasma gondii pneumonia manifests with fever, dyspnea and non-
productive cough. The most common finding on chest radiographs is bilateral diffuse 
interstitial infiltrates [8, 14, 16]. The clinical and radiological appearance may be 
indistinguishable from the far more common P. jiroveci pneumonia. As compared with 
pneumocystis pneumonia the clinical onset and the evolution of symptoms are more 
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rapid in toxoplasma pneumonia [8]. A blood level of LDH > 600 U/L is more likely to be 
associated with toxoplasmosis than pneumocystis pneumonia [17]. A toxoplasma 
antibody titer of >150 U/ml is an important predictor of cerebral and extracerebral 
toxoplasmosis [18]. Finally, pulmonary toxoplasmosis occurs mainly in patients with 
severe immunodeficiency, with a CD4 cell count of 40 ±75 cells/µl [14].  
     Mortality in immunosuppressed patients with pulmonary toxoplasmosis is high: in the 
French survey 37% of HIV-infected patients with toxoplasma pneumonia died [14] and in 
a metaanalysis mortality among immunosuppressed persons with pulmonary 
toxoplasmosis was 40% [16]. As toxoplasma pneumonitis is clinically difficult do 
diagnose and is associated with a considerable mortality, it is necessary to force the 
diagnosis by microbiological examination of respiratory samples. Especially in patients 
with severe clinical pictures or not responding to therapy, it is judicious to perform a BAL 
with cytological examination of BAL fluid, using appropriate special stains to detect 
toxoplasma organisms. In both of our cases, early diagnosis led to a favorable outcome. 
     In resource poor countries, for example in Africa with a toxoplasmosis 
seroprevalence of up to 78% [19] and more HIV-infected patients with very low CD4 cell 
counts, prevalence of pulmonary toxoplasmosis might be higher than in industrialized 
countries. However, in these countries diagnostic possibilities are often very limited and 
in the absence of respiratory samples clinicians need to consider an empiric toxoplasmal 
therapy, particularly in the presence of risk factors (see above) and non-responsiveness 
to therapy.   
     In summary, pulmonary toxoplasmosis is an infrequent but severe opportunistic 
infection in HIV-positive patients that still occurs in the era of HAART. The two cases 
emphasize the importance of considering toxoplasmosis early in the differential 
   9/15 
diagnosis in (potentially) HIV-infected patients presenting with respiratory symptoms and 
bilateral pulmonary infiltrates. Early diagnosis and initiating specific therapy is essential.
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Figure 1:  Chest radiograph and bronchoalveolar fluid of case 1: diffuse bilateral 
alveolar infiltrates (A); Giemsa staining (B) and indirect immunofluorescence staining (C) 
with toxoplasma tachyzoites (black arrowed). Chest CT-scan and bronchoalveolar fluid 
of case 2: extensive bilateral, patchy infiltrates (D); Giemsa staining (E) revealing 
toxoplasma tachyzoites (black arrowed) and P. jirovecii (red arrowed) and toluidine blue 
O staining with P. jirovecii (F).  
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